Anuh Pharma Ltd. వార్షిక వృద్ధి వివరాలు ఆధారంగా కంపెనీ చరిత్ర

1961 - Anuh Pharma Ltd was incorporated.

2006

- In early January, the promoters sold off nearly 14.9% of their stake in the company.

-Anuh Pharma has given the Bonus in the Ratio of 1:1

-Company has splits its Face value of Shares from Rs 10 to Rs 5

2010

-Anuh Pharma has given the Bonus in the Ratio of 2:1

2011

-Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00.

2012

-Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory.

-Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00.

2013

-Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00.

2014

-Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate.

-Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share.

2015

-The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1.

2016

-Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France.

2020

-The Company has issued Bonus Shares in the Ratio of 1:1.